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Abstract
Background/Aim. Multiple sclerosis (MS) is a chronic
autoimmune inflammatory disorder of the unknown origin
leading to multifocal demyelization, axonal damage and the
loss of the nervous tissue in various parts of the central
nervous system. Most MS patients have decreased function-
ality of the bladder leading to various dysuria disorders
during the course of the illness. However, in 2% of the
cases dysuric problems are the first symptoms of the dis-
ease. Urodynamic testing could help to diagnose functional
disorders of the lower urinary tract, which might not be
otherwise possible by performing the standard invasive pro-
cedures or noninvasive scans, such us ultrasound, computed
tomography or functional magnetic resonance imaging
(fMRI). Methods. Urodynamic testing – cystometry with
electromyographic (EMG) potentials from the external anal
sphincter (EAS), was performed in 34 patients (25 female
and 9 male patients). Those patients fulfilled Mc Donald’s
multiple sclerosis criteria. The urodynamic values were
compared to neurological signs and the present disease
symptoms. Results. The MS patients with (27) and without
(7) miction problems were tested. Detrusor hyperreflexia is
the most common finding, present in 58.8% of the cases.
More than a half of the patients have detrusor sphincter
dissynergia. Conclusions. Urodynamic testing helps us to
determine neurological disorders characteristics and to pre-
pare an appropriate treatment plan. During the course of
the disease different urodynamic disfunctions may occur as
well as changes in the urinating functionality. The rationale
for urodynamic testing in patients suffering from MS before
any other treatment procedure is to confirm the diagnosis
of dysuric disorders and to secure appropriate treatment.
Key words:
multiple sclerosis; urination disorders; urodynamics;
electromyography.
Apstrakt
Uvod/Cilj. Multipla skleroza (MS) je hroni no zapaljensko
autoimuno oboljenje nepoznate etiologije koje dovodi do
multifokalne demijelinizacije, ošte enja aksona i gubitka ner-
vnog tkiva u razli itim delovima centralnog nervnog sistema.
Ve ina bolesnika sa multiplom sklerozom ima i poreme enu
funkciju mokra ne bešike koja dovodi do razli itih dizuri nih
smetnji tokom trajanja bolesti. Samo kod 2% bolesnika ove
smetnje su prvi simptom bolesti. Urodinamsko ispitivanje
omogu ava nam da postavimo dijagnozu funkcionalnih po-
reme aja donjeg urinarnog trakta, što uobi ajenim invazivnim
procedurama ili neinvazivnim snimanjima (ultrazvuk, kom-
pjuterizovana tomografija ili funkcionalna magnetna rezonan-
ca) esto nije mogu e ustanoviti. Metode. Urodinamsko ispi-
tivanje – cistometrija i registrovanje elektromiografskih
(EMG) potencijala sa spoljašnjeg analnog sfinktera (SAS)
ura eno je kod 34 bolesnika (25 žena i 9 muškaraca), koji is-
punjavaju Mc Donaldove dijagnosti ke kriterijume za multi-
plu sklerozu. Dobijene vrednosti su upore ivane sa neurološ-
kom simptomatologijom i znacima bolesti. Rezultati. Ispiti-
vani su bolesnici sa (n = 27) i bez (n = 7) mikcionih tegoba.
Hiperrefleksija detrusor bila je naj eš i nalaz, prisutan ak kod
58,8% bolesnika. Više od polovine ovih bolesnika imalo je
detrusor-sfinkter disinergiju. Zaklju ak. Urodinamsko ispiti-
vanje može pomo i da se utvrde postoje i neurourološki po-
reme aji i na osnovu njih planira sprovo enje odgovaraju eg
terapijskog plana. Tokom trajanja bolesti mogu se ustanoviti
razli iti oblici urodinamskih nalaza disfunkcije, kao i promena
funkcije mokrenja. Razlog za sprovo enje urodinamskog is-
pitivanja kod bolesnika sa MS pre svake terapije bio bi posta-
vljanje jasne dijagnoze dizuri nih poreme aja koja bliže odre-
uje pravilnu i adekvatnu terapiju.
Klju ne re i:
multipla skleroza; mokrenje, poreme aji; urodinamika;
elektromiografija.
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Introduction
Multiple sclerosis (MS) is a chronic disease of the cen-
tral nervous system (CNS) characterized by the widespread
multifocal lesions in the brain and spinal cord, leading to
visual, sensory, motor and urogenital impairments. The first
attack of the disease usually occurs between the second and
third decade of life, affecting working and living activity of
the patients, depending on the severity and the diversity in
the clinical course of the disease 1, 2.
MS is the disease with extremely varying clinical ex-
pression, with remissions and exacerbations of different
symptoms, usually starting with visual impairments, weak-
ness of extremities, diplopia, sensory disturbances and gait
difficulties and disturbances, and urinary and anal sphincter
dysfunctions 3. Those dysfunctions comprise of frequent uri-
nating, urgency, incontinency, retention or hesitance. Ac-
cording to several studies, the incidence of dysuric disorders
in MS is 50–97% 3–5. The form of the present dysuric disor-
der depends on the size and the position of demyelinated
plaques. Therefore, any type and combination of neurogenic
bladder and sphincter dysfunctions is possible during the
course of the disease 6.
Urodynamic testing is a useful tool in lesion localiza-
tion, determination of neurogenic bladder type and might
help to apply the appropriate therapy protocol, based on
findings during the disease progression.
Urinary disturbances are caused by the lesion of the
neural systems controlling the act of miction, and the conse-
quences of these disturbances have to be monitored during
rehabilitation of the disease 4. Therefore, the aim of this
study was to choose adequate functional diagnostic tests
which could enable us to distinguish the causes of disturbed
urodinamics. Performing rehabilitation of MS patients with
neurogenic dysfunctions of urination enables preservation of
the anatomic integrity and functionality of the structures in-
volved in the act of urination. Depending on the phase of the
illness, and the type of dysuric disfunctions, proper therapies
and procedures should been applied.
Methods
At the Urodynamic Department, Clinic for Rehabilita-
tion “Dr Miroslav Zotovi ”, Belgrade, Serbia, patients with
urinary disturbances were tested. The testing protocol com-
prises of reviewing patients medical documentation, as well
as urodynamic testing. A total of 34 patients, 25 female and
9 male patients, previously diagnosed with MS were exam-
ined.
Medical data were obtained from anamnesis data, the
history of the disease, the order of the symptoms and signs of
the disease appearance, so the phases of exacerbation and
remission of the symptoms were noted. Obtaining data on
urination function is important, as well as the problem onset
and the type of dysuric disorders and the duration of the pre-
vious predicaments.
Prior to start of the urodynamic testing, post mictional
residual urine was determined. Also, laboratory analysis of
urine, urinoculture, blood analysis, sedimentation, and the
serum urea, creatinine, uric acid, bilirubin and glucose levels
were determined.
In order to choose adequate functional tests which
could enable distinguishing disturbances in urodynamics,
cystometry was used, combined with description of neuro-
genic dysfunction of urination. Measurement gives important
data concerning the act of urination – function of the bladder
and preserved sphincter mechanisms 7.
Urodynamic studies were performed using a Dantec
Logic (Dantec Inc, Copenhagen, Denmark). A double lumen
6–8 F urethral catheter was introduced and normal saline
solution (0.9% sodium chloride) was used at the rate of 10–
20 mL/min to fill the bladder. Bladder volume, maximum
bladder capacity, bladder compliance, vesical (Pves), abdomi-
nal (Pabd) and detrusor pressures (Pdet) were monitored si-
multaneously during the filling and voiding phases 8–10. Sur-
face electromyography of the external sphincter activity was
performed.
On the basis of urodynamic studies according to Inter-
national Continence Society standards 7, bladder dysfunction
was classified into 3 groups: detrusor areflexia (DA), defined
as acontractility caused by abnormality of nervous control,
and detrusor hyporeflexia, defined as detrusor contraction of
inadequate magnitude and/or duration to effect bladder
emptying in a normal time span. The patients with detrusor
areflexia and detrusor hyporeflexia were grouped together
for analyses due to the small sample size in our study and
similar procedure management; detrusor external sphincter
dyssynergia (DSD), defined as detrusor contraction concur-
rent with an involuntary contraction of the urethral and/or
periurethral striated muscle; detrusor hyperreflexia (DH), de-
fined as involuntary detrusor contraction during the filling
phase which may be spontaneous or provoked, and cannot be
completely suppressed due to disturbances of nervous con-
trol mechanisms.
The presence of urinary infection changes the severity
of the disease symptoms. Therefore, infection must be
treated early with the appropriate therapy before urody-
namic investigation takes place. At the time of urodynamic
investigation, patients were without urinary tract infection
and no drugs that influence detrusor and striated sphincter
behavior.
The numerical data are described by mean and their
standard deviations ( ± SD), and the categorical data are ex-
pressed as counts and percentages. The numerical data were
compared with the t-test, and 2-square or Fisher’s exact test
were used to compare the categorical data. Two-sided tests
are used, and p-value < 0.05 was considered to indicate sta-
tistical significance. All the data in the present study were
analyzed with the commercial statistical software (SPSS ver-
sion 13.0 for Windows; SPSS Inc, Chicago, Il, USA).
Results
The study included 34 MS patients – 25 (73.5%) fe-
males and 9 (26.5%) males with urinary symptoms and dis-
turbances (Table 1).
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Comparing the mean age of the patients at the moment of
testing, no statistically significant difference between the male
and female patients was found. The youngest participant was a
male, aged 15, and the oldest was a female patient, aged 57.
The average age at the onset of the disease was 30.1 years for
the female and 27.6 years for the male patients, and no statisti-
cally significant difference between the male and female pa-
tients was found concerning this parameter. Also, no signifi-
cant difference between the patients with or without bladder
symptoms was found (t = 0.62,  p > 0.05) (Table 1).
The duration of the disease varies from 1 to 15 years;
however, most patients had urinary dysfunctions in the range
from 1 to 6 years. There was no statistically significant dif-
ference in the duration of the disease between the females
and males also (Table 1). Most patients developed bladder
dysfunction several years after the first neurological symp-
toms but in 4 of the patients only urinary symptoms were
present at the time of the disease onset. However, urinary
dysfunction was not the sole presenting symptom of MS in
any of our patients.
A total of 27 (79.4%) patients suffered from dysuric dis-
turbances and in 7 (20.6%) patients no irritation or obstruction
was found. However, there was a statistically significant differ-
ence in the duration of the disease between the patients with and
without the symptoms concerning urinary system (Table 2).
The symptoms of irritation (urgency, frequency, urge
incontinency) were present in 59% of the symptomatic pa-
tients, contrary to obstructive symptoms (hesitancy, reten-
tion, interrupted stream, sensation of incomplete bladder
emptying) present in 41% of the symptomatic patients (Table
3). The most common urinary symptoms were irritative. Dif-
ficulty in initiating voluntary voiding was a concurrent
symptom in approximately half of the patients. The patients
with more severe bladder dysfunction became unable to void
voluntarily and could empty the bladder only when they had
spontaneous hyperreflexic detrusor contractions.
The relation between dysuric disturbances and the neu-
rological findings did not meet the criteria for applying
proper statistical tests, but the tendencies pointed to the oc-
currence of irritative disturbances combined with pyramidal
symptomatology. The majority of patients with MS and
lower limbs pyramidal signs (13 patients) had dysuric distur-
bances of both types (Figure 1).
Table 3
Distribution of urinary symptoms in the multiple sclerosis
(MS) patients
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Fig. 2 – An example of cystometry with electromyography
(EMG) of external anal sphincter in a patient with multiple
sclerosis (MS) (findings: small capacity, high detrusor
pressure, detrusor sfincter dyssinergia).
Vinfus = infusion fluid volume; Pves = vessical pressure; Pabd = abdominal
pressure, Pdet = detrusor pressure; FD = first desire to void.
Table 1
Demographic and clinical characteristics of the patients with urodynamic dysfunction (n = 34)
Demographic and clinical characteristics Female Male p
Number (%) 25 (73.5) 9 (26.5) < 0.01
Age of the moment of testing (years),  ± SD 32.6 ± 9.7 35.5 ± 10.4 n.s.
Age at the disease onset (years),  ± SD 30.1 ± 10.2 27.6 ± 9.1 n.s.
Years elapsed from the disease onset.  ± SD 5.3 ± 3.9 4.9 ± 3.4 n.s.
Years elapsed from the urodynamic dysfunction onset,  ± SD 4.3 ± 2.1 4.1 ± 1.9 n.s.
n.s. – no significant difference
Table 2
Correlation between the duration of the disease and the patients with and without urinary simptoms
Parameters Symptomatic Asymptomatic p
Number (%) of patients 27 (79.4) 7 (20.6) < 0.01
Disease duration (years),  ± SD 6.1 ± 3.7 1.7 ± 1.3 < 0.01
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Cystometry showed detrusor hyperreflexia in 20 (59%)
of the patients, detrusor areflexia in 10 (29%), normal detru-
sor activity in 4 (12%) of the patients, implying 3 more MS
patients (comparing to subjective report) with subclinical
urinary dysfunction who did not recognize symptoms.
Comparative analysis of EMG potential from the exter-
nal urethral sphincter (EUS) registered indirectly with cys-
tometrography via the external anal sphincter (EAS) (Fig-
ure 3), demonstrated a high occurrence of detrusor-sphincter
dissynergia in more than 40% of the patients (Figure 3).
Fig. 3 – Number of the patients with detrusor hyper- and
hyporeflexia related to external anal sphincter (EAS)
electromyographic (EMG) activity
(DSD = detrusor sphincter dyssynergia; NORM = normal EMG activity;
LOW = decreased EMG activity).
Discussion
The bladder, sphincter mechanisms and urethra forming
the terminal parts of the urinary tract can be seen as a func-
tional unit. Their basic function, filling the bladder, conti-
nence and miction make a group of very complex mecha-
nisms and activities of antagonistic groups of smooth and
skeletal muscles combined with complex innervations. The
interruption of the nervous pathways with occurrence of de-
myelinating plaques in multiple sclerosis causes different
forms of neurogenous bladder, with different disturbances
and outcomes during the disease progress.
Our study included 34 MS patients – 25 (73.5%) fe-
males and 9 (26.5%) males with urinary symptoms and dis-
turbances. It was in accordance with earlier studies, con-
firming predomination of female MS patients 3, 6, 11. Symp-
tom severity ranged from mild to very severe.
The most common urinary symptom of patients with
MS is urgency. Series of urodynamic studies have shown
that this is due to underlying detrusor hyperreflexia 3, 6, 12.
Urge incontinence is likely to be a problem if the patient also
had impaired mobility and difficulty to access a toilet 10, 13.
The symptoms of impaired voiding are usually less promi-
nent in testing and may be disclosed only during anamnesis
or self reports.
The most common urodynamic finding was detrusor
hyperreflexia suggesting that MS patients with irritative
bladder symptoms and with lower limb pyramidal involve-
ment are highly likely to have detrusor hyperreflexia. How-
ever, the explanation for detrusor areflexia in MS remains
uncertain. Several investigators have reported that in some
patients with MS initial urodynamic tests showed detrusor
areflexia but subsequent studies demonstrated also hyperre-
flexia 5, 6, 12. The neurological basis for this complete change
in detrusor activity remains unclear 11.
Similar findings related to DSD in our study were also
reported in previous studies 14, 15, although with significant
differences in DSD appearance between patients with hiper-
reflexic and hyporeflexic bladder. The urodynamic finding of
hyperreflexia correlated well with the symptoms of urgency,
frequency and urge incontinence 16.
A modern concept of neural control of the bladder is
based on long loop reflexes via the pontine tegmentum 3, 10, 16.
Pathways interruption between the sacral cord and pons may
result in detrusor hyperreflexia and the loss of a coordinated
action of a detrusor and the external striated urethral sphinc-
ter during voiding, the condition known as DSD. The re-
ported incidence of DSD in MS patients varies from 18% to
66% 16. DSD is important in the treatment of MS patients
due to the tendency for incomplete bladder emptying, ac-
companied by poorly sustained detrusor contractions 10, 17.
Hesitancy of micturition, interrupted urinary stream and the
finding of a high postmicturition residual volume in a patient
with spinal cord disease therefore suggest DSD.
Applying classical urological diagnostic procedures
could help to describe changes in parts of the lower urinary
tract. Functional diagnostics provides monitoring and regis-
tering parameters of urination during filling and emptying of
the bladder at approximately physiological conditions. Col-
lected data could describe the degree of damage of bladder
function as a consequence of the present CNS lesions 11, 18. It
is evident that in MS patients urodynamic findings can be
changed through the disease duration, as well as the neuro-
logical signs and symptoms 10. Different forms of dysfunc-
tions are the result of the form of the disease, and the char-
acter and localization of demyelinating plaques in MS. Some
of those signs and symptoms may develop before neurologi-
cal changes, therefore urodynamic testing should be a part of
routine testing of the disease, especially in patients develop-
ing changes during the course of the disease.
Appropriate therapeutic planning should be based on
urodynamic findings. Some authors state that there is a poor
correlation between subjective discomfort and objective neu-
rological parameters 1, 2, 11, 19. Therefore, neurological testing
has important role not only in patients with dysuric distur-
bances, but also in patients without urinary discomfort,
which was shown in this study.
By combining cystometry and EMG of EAS it is possi-
ble to register the occurrence of detrusor sphincter dissinergy
which is an important urodynamic indicator of the progres-
sion of the disease disturbances (Figure 2). Those findings
combined with hyperreflexia of m. detrusor appear to be
most important urodynamic finding in patients during pro-
gressing MS. The data described here as neurogenous dys-
function of the bladder are in agreement with the criteria ac-
cording to meta-analyses of urodynamic findings of 22 stud-
ies with 1882 patients diagnosed with MS 4.
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Analysis of the urodynamic findings of this study em-
phasizes significant changes in the function of the bladder in
MS patients, which further deteriorate their clinical picture
and symptoms during the course and progression of the dis-
ease. During the progression of the disease, bladder dysfunc-
tion may become more and more difficult to treat. Main rea-
sons could be described as worsening detrusor hyperreflexia,
decreased efficiency in emptying due to worsening of the
paraparesis neurological condition, appearance of recurrent
urinary infections, spasticity and worsening of patients general
immobility, and possibly their cognitive impairment 10, 20.
Conclusion
Based on the findings of this study we can conclude
that: urodynamic tests of dysuric disturbances enable us to
properly describe and monitor changes in factors of urina-
tion; the results of testing show the severity of urinary tract
disturbances in patients with MS; the results of urodynamic
test allow as to  make appropriate urinary bladder training in
patients with MS; an early therapeutic approach to preserva-
tion of physiological features of the bladder (elasticity and
contractility) is very important due to the fact that satisfac-
tory effect of the newly reorganized nervous control can be
valid only in case of preserved physiological functions and
structures. However, higher number of patients and broader
variety of applied tests might give clearer perspective of uri-
nary dysfunctions treatment in MS patients with different
MS subtypes and forms.
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